Attached files
file | filename |
---|---|
10-K - NANOVIRICIDES INC 10-K 6-30-2009 - NANOVIRICIDES, INC. | form10k.htm |
EX-31.1 - EXHIBIT 31.1 - NANOVIRICIDES, INC. | ex31_1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
The
undersigned, Eugene Seymour, MD, Chief Executive and Financial Officer of
NanoViricides, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
(1)
|
the
annual report on Form 10-K of NanoViricides, Inc. for the period ended
June 30, 2009 (the “Report”) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
|
|
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of
NanoViricides, Inc.
|
Dated:
October 13, 2009
/s/
Eugene Seymour
|
|
Eugene
Seymour
|
|
Chief
Executive and Interim Financial Officer
|
|
(Principal
Executive, Financial and Accounting
Officer)
|
A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to NanoViricides, Inc. and will be retained by
NanoViricides, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.